id stringlengths 11 11 | tags stringlengths 10 777 | text stringlengths 2 1.5k | dataset_num int64 1 3 | tokens list | ner_tags list |
|---|---|---|---|---|---|
NCT02908906 | 29:61:treatment | Treatment with any local or systemic anti-neoplastic therapy | 2 | [
"Treatment",
"with",
"any",
"local",
"or",
"systemic",
"anti-neoplastic",
"therapy"
] | [
0,
0,
0,
0,
0,
1,
1,
1
] |
NCT02592551 | 23:31:treatment,,119:127:treatment,131:150:treatment | Receipt of drugs with laxative properties and herbal or natural remedies for constipation within 90 days of receiving MEDI4736 or MEDI + tremelimumab | 2 | [
"Receipt",
"of",
"drugs",
"with",
"laxative",
"properties",
"and",
"herbal",
"or",
"natural",
"remedies",
"for",
"constipation",
"within",
"90",
"days",
"of",
"receiving",
"MEDI4736",
"or",
"MEDI",
"+",
"tremelimumab"
] | [
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
1,
1
] |
NCT02503722 | 18:36:chronic_disease | Prior history of corneal ulceration | 2 | [
"Prior",
"history",
"of",
"corneal",
"ulceration"
] | [
0,
0,
0,
2,
2
] |
NCT01946074 | 17:36:treatment,64:72:treatment,77:94:treatment | Subjects in the combination therapy cohorts who are to receive ABBV-181, an anti-PD1 antibody, must also meet other criteria described in the Protocol | 2 | [
"Subjects",
"in",
"the",
"combination",
"therapy",
"cohorts",
"who",
"are",
"to",
"receive",
"ABBV-181",
",",
"an",
"anti-PD1",
"antibody",
",",
"must",
"also",
"meet",
"other",
"criteria",
"described",
"in",
"the",
"Protocol"
] | [
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
1,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02309580 | 29:60:treatment, | Patients who have undergone allogeneic stem cell transplant > 12 months | 2 | [
"Patients",
"who",
"have",
"undergone",
"allogeneic",
"stem",
"cell",
"transplant",
">",
"12",
"months"
] | [
0,
0,
0,
0,
1,
1,
1,
1,
0,
0,
0
] |
NCT02019641 | 25:40:treatment | Active participation in ILD drug trials | 2 | [
"Active",
"participation",
"in",
"ILD",
"drug",
"trials"
] | [
0,
0,
0,
1,
1,
1
] |
NCT02924402 | 25:34:chronic_disease,36:41:chronic_disease,43:82:chronic_disease, | Evidence of any serious bacterial, viral, parasitic or systemic fungal infections within the 30 days prior to study entry | 2 | [
"Evidence",
"of",
"any",
"serious",
"bacterial",
",",
"viral",
",",
"parasitic",
"or",
"systemic",
"fungal",
"infections",
"within",
"the",
"30",
"days",
"prior",
"to",
"study",
"entry"
] | [
0,
0,
0,
0,
2,
0,
2,
0,
2,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02584244 | 17:23:cancer | Subjects at any cancer stage will be enrolled | 2 | [
"Subjects",
"at",
"any",
"cancer",
"stage",
"will",
"be",
"enrolled"
] | [
0,
0,
0,
3,
0,
0,
0,
0
] |
NCT02361554 | ,70:80:treatment | Subject is able to read English, understand and cooperate with study procedures, and has signed a written informed consent form prior to any study procedures | 2 | [
"Subject",
"is",
"able",
"to",
"read",
"English",
",",
"understand",
"and",
"cooperate",
"with",
"study",
"procedures",
",",
"and",
"has",
"signed",
"a",
"written",
"informed",
"consent",
"form",
"prior",
"to",
"any",
"study",
"procedures"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02525692 | 27:44:treatment,60:104:treatment,134:143:treatment, | Concomitant use of potent CYP3A4/5 inducers, which include enzyme inducing antiepileptic drugs (EIAEDs) (see Appendix B), during the treatment phase of the study and within 2 weeks prior to starting treatment | 2 | [
"Concomitant",
"use",
"of",
"potent",
"CYP3A4/5",
"inducers",
",",
"which",
"include",
"enzyme",
"inducing",
"antiepileptic",
"drugs",
"(",
"EIAEDs",
")",
"(",
"see",
"Appendix",
"B",
")",
",",
"during",
"the",
"treatment",
"phase",
"of",
"the",
"study",
"an... | [
0,
0,
0,
0,
1,
1,
0,
0,
0,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03080142 | 33:51:treatment | Patients scheduled for elective colorectal surgery with Dr. Linda Farkas | 2 | [
"Patients",
"scheduled",
"for",
"elective",
"colorectal",
"surgery",
"with",
"Dr.",
"Linda",
"Farkas"
] | [
0,
0,
0,
0,
1,
1,
0,
0,
0,
0
] |
NCT03157492 | ,45:47:treatment | Greater than three years post-activation of CI | 2 | [
"Greater",
"than",
"three",
"years",
"post-activation",
"of",
"CI"
] | [
0,
0,
0,
0,
0,
0,
1
] |
NCT01996449 | 1:14:treatment | phenylephrine | 2 | [
"phenylephrine"
] | [
1
] |
NCT02457845 | 1:34:treatment | Autologous bone marrow transplant | 2 | [
"Autologous",
"bone",
"marrow",
"transplant"
] | [
1,
1,
1,
1
] |
NCT00492778 | 1:31:chronic_disease,, | Neuropathy (sensory and motor) =< CTCAE v 3.0 grade 1 | 2 | [
"Neuropathy",
"(",
"sensory",
"and",
"motor",
")",
"=",
"<",
"CTCAE",
"v",
"3.0",
"grade",
"1"
] | [
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03088033 | 21:29:treatment,, | Currently requiring dialysis; or estimated-GFR <25ml/min/1.73 m2 by CKD-Epi equation | 2 | [
"Currently",
"requiring",
"dialysis",
";",
"or",
"estimated-GFR",
"<",
"25ml/min/1.73",
"m2",
"by",
"CKD-Epi",
"equation"
] | [
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02641093 | 11:29:cancer | Confirmed metastatic disease | 2 | [
"Confirmed",
"metastatic",
"disease"
] | [
0,
3,
3
] |
NCT02312596 | 1:6:chronic_disease,39:60:treatment,68:72:treatment | Ulcer expected to be treated with any advanced therapeutics (e.g., HBOT) | 2 | [
"Ulcer",
"expected",
"to",
"be",
"treated",
"with",
"any",
"advanced",
"therapeutics",
"(",
"e.g.",
",",
"HBOT",
")"
] | [
2,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
1,
0
] |
NCT01869114 | 33:44:treatment,48:58:treatment,96:99:chronic_disease | Patient may have previously had azacitidine or decitabine will be eligible to enroll on Arm A (MDS) | 2 | [
"Patient",
"may",
"have",
"previously",
"had",
"azacitidine",
"or",
"decitabine",
"will",
"be",
"eligible",
"to",
"enroll",
"on",
"Arm",
"A",
"(",
"MDS",
")"
] | [
0,
0,
0,
0,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0
] |
NCT02415556 | 1:9:chronic_disease,, | Dementia (Mini Mental State Examination [MMSE] scores ≤20) | 2 | [
"Dementia",
"(",
"Mini",
"Mental",
"State",
"Examination",
"[",
"MMSE",
"]",
"scores",
"≤20",
")"
] | [
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02378428 | 88:105:treatment | Patients with disease of any major organ system that would compromise their ability to withstand therapy | 2 | [
"Patients",
"with",
"disease",
"of",
"any",
"major",
"organ",
"system",
"that",
"would",
"compromise",
"their",
"ability",
"to",
"withstand",
"therapy"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT01620216 | 5:36:cancer,38:53:treatment,58:73:treatment,86:94:treatment,99:107:treatment,111:120:treatment,124:133:treatment | for Philadelphia positive (Ph+) ALL, initial therapy and salvage therapy may include steroids and imatinib or dasatinib or nilotinib | 2 | [
"for",
"Philadelphia",
"positive",
"(",
"Ph+",
")",
"ALL",
",",
"initial",
"therapy",
"and",
"salvage",
"therapy",
"may",
"include",
"steroids",
"and",
"imatinib",
"or",
"dasatinib",
"or",
"nilotinib"
] | [
0,
3,
3,
3,
3,
0,
0,
0,
1,
1,
0,
1,
1,
0,
0,
1,
0,
1,
0,
1,
0,
1
] |
NCT02385110 | 33:61:chronic_disease | A documentation of diagnosis of hemophagocytic lymphocytosis, either newly diagnosed or relapsed/refractory by the treating physician and the PI in the patients chart | 2 | [
"A",
"documentation",
"of",
"diagnosis",
"of",
"hemophagocytic",
"lymphocytosis",
",",
"either",
"newly",
"diagnosed",
"or",
"relapsed/refractory",
"by",
"the",
"treating",
"physician",
"and",
"the",
"PI",
"in",
"the",
"patients",
"chart"
] | [
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02021578 | 24:43:chronic_disease | Current diagnosis of a depressive disorder (child) | 2 | [
"Current",
"diagnosis",
"of",
"a",
"depressive",
"disorder",
"(",
"child",
")"
] | [
0,
0,
0,
0,
2,
2,
0,
0,
0
] |
NCT02095808 | 1:14:chronic_disease | Heart failure | 2 | [
"Heart",
"failure"
] | [
2,
2
] |
NCT02243813 | ,157:173:chronic_disease | Current or past history within the last 5 years of meeting DSM-5 criteria for alcohol or substance use disorder (excluding caffeine and nicotine) or severe major depression | 2 | [
"Current",
"or",
"past",
"history",
"within",
"the",
"last",
"5",
"years",
"of",
"meeting",
"DSM-5",
"criteria",
"for",
"alcohol",
"or",
"substance",
"use",
"disorder",
"(",
"excluding",
"caffeine",
"and",
"nicotine",
")",
"or",
"severe",
"major",
"depression"... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2
] |
NCT02576444 | 13:19:cancer | Progressive cancer at the time of study entry | 2 | [
"Progressive",
"cancer",
"at",
"the",
"time",
"of",
"study",
"entry"
] | [
0,
3,
0,
0,
0,
0,
0,
0
] |
NCT02578641 | 5:11:cancer, | any cancer curatively treated >3 years prior to study entry | 2 | [
"any",
"cancer",
"curatively",
"treated",
">",
"3",
"years",
"prior",
"to",
"study",
"entry"
] | [
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02138617 | 20:37:treatment | Willing to undergo UGT1A1 genotyping | 2 | [
"Willing",
"to",
"undergo",
"UGT1A1",
"genotyping"
] | [
0,
0,
0,
1,
1
] |
NCT02011971 | 18:36:treatment | Use of centrally active medications | 2 | [
"Use",
"of",
"centrally",
"active",
"medications"
] | [
0,
0,
0,
1,
1
] |
NCT02158234 | 13:31:cancer | Evidence of distant metastases | 2 | [
"Evidence",
"of",
"distant",
"metastases"
] | [
0,
0,
3,
3
] |
NCT02046330 | ,128:142:treatment,,201:208:treatment,210:212:treatment,214:224:treatment,226:238:treatment,240:255:treatment,257:266:treatment,273:302:treatment | adequate trials ( equal>4 weeks at the usually recommended or maximum tolerated dose) of augmentation/combination of a primary antidepressant using at least 2 different augmenting/combination agents (lithium, T3, stimulants, neuroleptics, anticonvulsants, buspirone, or a second primary antidepressant) | 2 | [
"adequate",
"trials",
"(",
"equal",
">",
"4",
"weeks",
"at",
"the",
"usually",
"recommended",
"or",
"maximum",
"tolerated",
"dose",
")",
"of",
"augmentation/combination",
"of",
"a",
"primary",
"antidepressant",
"using",
"at",
"least",
"2",
"different",
"augmenti... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
0,
0,
1,
1,
1,
0
] |
NCT01908777 | 19:22:treatment,47:94:chronic_disease,96:115:chronic_disease,120:131:chronic_disease,, | Other significant ECG abnormalities including 2nd degree atrio-ventricular (AV) block type II, 3rd degree AV block, or bradycardia (ventricular rate less than 50 beats/min) | 2 | [
"Other",
"significant",
"ECG",
"abnormalities",
"including",
"2nd",
"degree",
"atrio-ventricular",
"(",
"AV",
")",
"block",
"type",
"II",
",",
"3rd",
"degree",
"AV",
"block",
",",
"or",
"bradycardia",
"(",
"ventricular",
"rate",
"less",
"than",
"50",
"beats/mi... | [
0,
0,
1,
0,
0,
2,
2,
2,
2,
2,
2,
2,
0,
0,
0,
2,
2,
2,
2,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01553071 | 1:18:treatment,20:32:treatment,,,94:105:treatment,109:120:treatment,140:151:treatment,154:162:treatment | Radiation therapy, chemotherapy, and other investigational agents within 3weeks (6 weeks for nitrosourea or mitomycin C) prior to starting fenretinide + safingol | 2 | [
"Radiation",
"therapy",
",",
"chemotherapy",
",",
"and",
"other",
"investigational",
"agents",
"within",
"3weeks",
"(",
"6",
"weeks",
"for",
"nitrosourea",
"or",
"mitomycin",
"C",
")",
"prior",
"to",
"starting",
"fenretinide",
"+",
"safingol"
] | [
1,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
1,
0,
0,
0,
0,
1,
0,
1
] |
NCT02437370 | 6:24:chronic_disease | Have measurable disease based on Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 | 2 | [
"Have",
"measurable",
"disease",
"based",
"on",
"Response",
"Evaluation",
"Criteria",
"in",
"Solid",
"Tumors",
"(",
"RECIST",
")",
"1.1"
] | [
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03113695 | ,,,,,166:175:treatment | Females of childbearing potential (FCBP) must have a negative serum or urine pregnancy test within 10 - 14 days prior to and again within 24 hours prior to starting REVLIMID® | 2 | [
"Females",
"of",
"childbearing",
"potential",
"(",
"FCBP",
")",
"must",
"have",
"a",
"negative",
"serum",
"or",
"urine",
"pregnancy",
"test",
"within",
"10",
"-",
"14",
"days",
"prior",
"to",
"and",
"again",
"within",
"24",
"hours",
"prior",
"to",
"startin... | [
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1
] |
NCT01660607 | 1:29:chronic_disease | Myeloproliferative syndromes | 2 | [
"Myeloproliferative",
"syndromes"
] | [
2,
2
] |
NCT02341287 | ,,,144:160:treatment,168:178:treatment | Have difficulty initiating sleep for at least two-weeks, including a sleep latency of at least 30-minutes, three days per week (as measured by wrist actigraphy and/or sleep logs) | 2 | [
"Have",
"difficulty",
"initiating",
"sleep",
"for",
"at",
"least",
"two-weeks",
",",
"including",
"a",
"sleep",
"latency",
"of",
"at",
"least",
"30-minutes",
",",
"three",
"days",
"per",
"week",
"(",
"as",
"measured",
"by",
"wrist",
"actigraphy",
"and/or",
"... | [
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0
] |
NCT02378428 | ,,78:95:treatment | the presence of a partial response (PR) with high Curie score (>2) following induction therapy | 2 | [
"the",
"presence",
"of",
"a",
"partial",
"response",
"(",
"PR",
")",
"with",
"high",
"Curie",
"score",
"(",
">",
"2",
")",
"following",
"induction",
"therapy"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02556606 | 12:25:chronic_disease,27:51:chronic_disease,59:77:chronic_disease,82:98:chronic_disease | History of schizophrenia, schizoaffective disorder or any psychotic disorder, or bipolar disorder | 2 | [
"History",
"of",
"schizophrenia",
",",
"schizoaffective",
"disorder",
"or",
"any",
"psychotic",
"disorder",
",",
"or",
"bipolar",
"disorder"
] | [
0,
0,
2,
0,
2,
2,
0,
0,
2,
2,
0,
0,
2,
2
] |
NCT02274116 | 12:28:treatment | concurrent physical therapy | 2 | [
"concurrent",
"physical",
"therapy"
] | [
0,
1,
1
] |
NCT02111850 | 24:30:chronic_disease,38:61:chronic_disease,92:111:chronic_disease,113:136:chronic_disease,161:172:chronic_disease,194:216:chronic_disease | Clinically significant atrial and or ventricular arrhythmias including but not limited to: atrial fibrillation, ventricular tachycardia, second or third degree heart block or have a history of ischemic heart disease, or chest pain | 2 | [
"Clinically",
"significant",
"atrial",
"and",
"or",
"ventricular",
"arrhythmias",
"including",
"but",
"not",
"limited",
"to",
":",
"atrial",
"fibrillation",
",",
"ventricular",
"tachycardia",
",",
"second",
"or",
"third",
"degree",
"heart",
"block",
"or",
"have",
... | [
0,
0,
2,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0
] |
NCT02021279 | 46:64:treatment | Subject is to planning to undergo concurrent surgical treatment of prolapse using mesh other than the MatriStem Pelvic Floor Matrix | 2 | [
"Subject",
"is",
"to",
"planning",
"to",
"undergo",
"concurrent",
"surgical",
"treatment",
"of",
"prolapse",
"using",
"mesh",
"other",
"than",
"the",
"MatriStem",
"Pelvic",
"Floor",
"Matrix"
] | [
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02597985 | 1:21:chronic_disease | Advanced Parkinson's | 2 | [
"Advanced",
"Parkinson",
"'s"
] | [
2,
2,
0
] |
NCT01666080 | 1:16:treatment | Transplantation using sufficiently matched related donors (such as matched siblings) or unrelated donors | 2 | [
"Transplantation",
"using",
"sufficiently",
"matched",
"related",
"donors",
"(",
"such",
"as",
"matched",
"siblings",
")",
"or",
"unrelated",
"donors"
] | [
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02341300 | ,98:113:treatment, | Women with severe chronic illness and high likelihood of preterm birth and/or expected long-term hospitalizations during pregnancy | 2 | [
"Women",
"with",
"severe",
"chronic",
"illness",
"and",
"high",
"likelihood",
"of",
"preterm",
"birth",
"and/or",
"expected",
"long-term",
"hospitalizations",
"during",
"pregnancy"
] | [
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1
] |
NCT02189889 | 12:18:chronic_disease, | history of stroke within the last 6 months | 2 | [
"history",
"of",
"stroke",
"within",
"the",
"last",
"6",
"months"
] | [
0,
0,
2,
0,
0,
0,
0,
0
] |
NCT02187848 | 47:67:treatment | non-resolution of toxicities induced by these anticancer therapies | 2 | [
"non-resolution",
"of",
"toxicities",
"induced",
"by",
"these",
"anticancer",
"therapies"
] | [
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT01842399 | 10:13:treatment, | If their FSH test is more than 20, they will be considered menopausal | 2 | [
"If",
"their",
"FSH",
"test",
"is",
"more",
"than",
"20",
",",
"they",
"will",
"be",
"considered",
"menopausal"
] | [
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02445768 | 27:33:chronic_disease | having ever experienced a stroke | 2 | [
"having",
"ever",
"experienced",
"a",
"stroke"
] | [
0,
0,
0,
0,
2
] |
NCT02861417 | 22:36:treatment | Patients must have a haploidentical related donor or a fully matched related or unrelated donor | 2 | [
"Patients",
"must",
"have",
"a",
"haploidentical",
"related",
"donor",
"or",
"a",
"fully",
"matched",
"related",
"or",
"unrelated",
"donor"
] | [
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02983240 | 1:20:chronic_disease | Severe preeclampsia | 2 | [
"Severe",
"preeclampsia"
] | [
2,
2
] |
NCT02410954 | 8:19:treatment, | Use of medications known to affect Central Nervous System (CNS) function within 5 half-lives screening | 2 | [
"Use",
"of",
"medications",
"known",
"to",
"affect",
"Central",
"Nervous",
"System",
"(",
"CNS",
")",
"function",
"within",
"5",
"half-lives",
"screening"
] | [
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03146663 | ,23:61:treatment | Received fewer than 3 prior chemotherapy-containing regimens | 2 | [
"Received",
"fewer",
"than",
"3",
"prior",
"chemotherapy-containing",
"regimens"
] | [
0,
0,
0,
0,
1,
1,
1
] |
NCT03152409 | 12:20:chronic_disease | History of GI bleed | 2 | [
"History",
"of",
"GI",
"bleed"
] | [
0,
0,
2,
2
] |
NCT02516670 | 1:22:chronic_disease,24:34:treatment,36:46:treatment | Gastrointestinal (GI): cimetidine, aprepitant | 2 | [
"Gastrointestinal",
"(",
"GI",
")",
":",
"cimetidine",
",",
"aprepitant"
] | [
2,
2,
0,
0,
0,
1,
0,
1
] |
NCT01817751 | 59:72:treatment | Any condition that would prohibit patient from initiating valproic acid | 2 | [
"Any",
"condition",
"that",
"would",
"prohibit",
"patient",
"from",
"initiating",
"valproic",
"acid"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT01804465 | 11:17:cancer | Any other cancer from which the patient has been disease-free for 5 years | 2 | [
"Any",
"other",
"cancer",
"from",
"which",
"the",
"patient",
"has",
"been",
"disease-free",
"for",
"5",
"years"
] | [
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01676753 | 43:82:allergy_name | Patient has known hypersensitivity to the components of study drug or its analogs | 2 | [
"Patient",
"has",
"known",
"hypersensitivity",
"to",
"the",
"components",
"of",
"study",
"drug",
"or",
"its",
"analogs"
] | [
0,
0,
0,
0,
0,
0,
4,
4,
4,
4,
4,
4,
4
] |
NCT01742338 | 36:43:chronic_disease,45:61:chronic_disease,65:70:chronic_disease | Alternative diagnosis for cause of dyspnea, increased sputum or cough | 2 | [
"Alternative",
"diagnosis",
"for",
"cause",
"of",
"dyspnea",
",",
"increased",
"sputum",
"or",
"cough"
] | [
0,
0,
0,
0,
0,
2,
0,
2,
2,
0,
2
] |
NCT02515110 | 23:43:cancer,47:82:cancer,91:109:cancer,110:132:treatment | complete resection of basal cell carcinoma or squamous cell carcinoma of the skin and any in situ malignancy after curative therapy | 2 | [
"complete",
"resection",
"of",
"basal",
"cell",
"carcinoma",
"or",
"squamous",
"cell",
"carcinoma",
"of",
"the",
"skin",
"and",
"any",
"in",
"situ",
"malignancy",
"after",
"curative",
"therapy"
] | [
0,
0,
0,
3,
3,
3,
0,
3,
3,
3,
3,
3,
3,
0,
0,
3,
3,
3,
1,
1,
1
] |
NCT02192398 | 17:39:treatment,49:61:treatment,78:89:chronic_disease,97:108:treatment | Subjects are on antihypertensive drugs (e.g., a beta-blocker) that result in hypotension and/or bradycardia as defined above | 2 | [
"Subjects",
"are",
"on",
"antihypertensive",
"drugs",
"(",
"e.g.",
",",
"a",
"beta-blocker",
")",
"that",
"result",
"in",
"hypotension",
"and/or",
"bradycardia",
"as",
"defined",
"above"
] | [
0,
0,
0,
1,
1,
0,
0,
0,
0,
1,
0,
0,
0,
0,
2,
0,
1,
0,
0,
0
] |
NCT01562626 | 1:21:chronic_disease | patent foramen ovale | 2 | [
"patent",
"foramen",
"ovale"
] | [
2,
2,
2
] |
NCT02411656 | 13:23:cancer,36:49:cancer,58:78:cancer,82:117:cancer,130:145:cancer,177:193:treatment | Has a known malignancy (other than breast cancer) except basal cell carcinoma or squamous cell carcinoma of the skin, or in situ cervical cancer that has undergone potentially curative therapy | 2 | [
"Has",
"a",
"known",
"malignancy",
"(",
"other",
"than",
"breast",
"cancer",
")",
"except",
"basal",
"cell",
"carcinoma",
"or",
"squamous",
"cell",
"carcinoma",
"of",
"the",
"skin",
",",
"or",
"in",
"situ",
"cervical",
"cancer",
"that",
"has",
"undergone",
... | [
0,
0,
0,
3,
0,
0,
0,
3,
3,
0,
0,
3,
3,
3,
0,
3,
3,
3,
3,
3,
3,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
1,
1
] |
NCT02885649 | 1:33:chronic_disease | Retroperitoneal/hilar adenopathy concerning for locally advanced disease | 2 | [
"Retroperitoneal/hilar",
"adenopathy",
"concerning",
"for",
"locally",
"advanced",
"disease"
] | [
2,
2,
0,
0,
0,
0,
0
] |
NCT03004287 | 22:42:cancer | Diagnosis of primary plasma cell leukemia | 2 | [
"Diagnosis",
"of",
"primary",
"plasma",
"cell",
"leukemia"
] | [
0,
0,
0,
3,
3,
3
] |
NCT02496663 | 15:30:treatment | Any number of prior therapies is allowed | 2 | [
"Any",
"number",
"of",
"prior",
"therapies",
"is",
"allowed"
] | [
0,
0,
0,
1,
1,
0,
0
] |
NCT03135145 | 14:30:treatment | referred for physical therapy for mobility/gait training to regain functional walking and ambulation | 2 | [
"referred",
"for",
"physical",
"therapy",
"for",
"mobility/gait",
"training",
"to",
"regain",
"functional",
"walking",
"and",
"ambulation"
] | [
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02501954 | 1:8:treatment,30:42:treatment,47:77:treatment | Surgery must have included a hysterectomy and bilateral salpingooophorectomy | 2 | [
"Surgery",
"must",
"have",
"included",
"a",
"hysterectomy",
"and",
"bilateral",
"salpingooophorectomy"
] | [
1,
0,
0,
0,
0,
1,
0,
1,
1
] |
NCT02342782 | 1:24:chronic_disease,25:40:chronic_disease,44:71:chronic_disease | Active hepatitis B or C viral infection or hepatitis B surface antigen positive | 2 | [
"Active",
"hepatitis",
"B",
"or",
"C",
"viral",
"infection",
"or",
"hepatitis",
"B",
"surface",
"antigen",
"positive"
] | [
2,
2,
2,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT03073070 | 12:39:chronic_disease | history of gastrointestinal blood loss | 2 | [
"history",
"of",
"gastrointestinal",
"blood",
"loss"
] | [
0,
0,
2,
2,
2
] |
NCT02553447 | 31:64:treatment | Simultaneous participation in other therapeutic clinical trials will be allowed | 2 | [
"Simultaneous",
"participation",
"in",
"other",
"therapeutic",
"clinical",
"trials",
"will",
"be",
"allowed"
] | [
0,
0,
0,
1,
1,
1,
1,
0,
0,
0
] |
NCT03109431 | 13:26:chronic_disease | Established HIV infection (not acutely infected) | 2 | [
"Established",
"HIV",
"infection",
"(",
"not",
"acutely",
"infected",
")"
] | [
0,
2,
2,
0,
0,
0,
0,
0
] |
NCT03065465 | 7:24:chronic_disease,, | Acute hypovolemic shock that is unresponsive to transfusion of 5 or more units of red blood cells (RBC's) | 2 | [
"Acute",
"hypovolemic",
"shock",
"that",
"is",
"unresponsive",
"to",
"transfusion",
"of",
"5",
"or",
"more",
"units",
"of",
"red",
"blood",
"cells",
"(",
"RBC",
"'s",
")"
] | [
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01983462 | 8:44:treatment,52:59:treatment,61:68:treatment,70:78:treatment,83:91:treatment,94:110:treatment,118:128:treatment,130:139:treatment,144:155:treatment,158:165:treatment | Taking Phosphodiesterase (PDE) 5 inhibitors (e.g., Viagra®, Cialis®, Levitra®, or Revatio®); PDE 3 inhibitors (e.g., cilostazol, milrinone, or vesnarinone); lithium | 2 | [
"Taking",
"Phosphodiesterase",
"(",
"PDE",
")",
"5",
"inhibitors",
"(",
"e.g.",
",",
"Viagra®",
",",
"Cialis®",
",",
"Levitra®",
",",
"or",
"Revatio®",
")",
";",
"PDE",
"3",
"inhibitors",
"(",
"e.g.",
",",
"cilostazol",
",",
"milrinone",
",",
"or",
"vesn... | [
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1
] |
NCT02339922 | 31:49:chronic_disease,64:75:chronic_disease,79:80:chronic_disease,81:96:chronic_disease,107:141:chronic_disease | Known ongoing or known active systemic infection, known active hepatitis B or C virus infection, or known human immunodeficiency virus (HIV) positive | 2 | [
"Known",
"ongoing",
"or",
"known",
"active",
"systemic",
"infection",
",",
"known",
"active",
"hepatitis",
"B",
"or",
"C",
"virus",
"infection",
",",
"or",
"known",
"human",
"immunodeficiency",
"virus",
"(",
"HIV",
")",
"positive"
] | [
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
2,
2,
0,
2,
2,
2,
0,
0,
0,
2,
2,
2,
2,
0,
0,
0
] |
NCT02213068 | 1:4:chronic_disease | EBV seropositive | 2 | [
"EBV",
"seropositive"
] | [
2,
0
] |
NCT02016235 | 54:88:chronic_disease,110:129:chronic_disease,,,164:180:chronic_disease,199:217:treatment,219:234:treatment,239:248:treatment, | Exclusion criteria include history of symptomatic or asymptomatic kidney stone disease; primary or secondary hyperparathyroidism; estimated GFR <40 ml/min/1.73m2, chronic diarrhea states; intake of thiazide diuretics, glucocorticoids, or estrogens within one month of the study | 2 | [
"Exclusion",
"criteria",
"include",
"history",
"of",
"symptomatic",
"or",
"asymptomatic",
"kidney",
"stone",
"disease",
";",
"primary",
"or",
"secondary",
"hyperparathyroidism",
";",
"estimated",
"GFR",
"<",
"40",
"ml/min/1.73m2",
",",
"chronic",
"diarrhea",
"states... | [
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
2,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
1,
1,
0,
1,
0,
0,
1,
0,
0,
0,
0,
0,
0
] |
NCT02004275 | 24:59:treatment,47:59:treatment,61:71:treatment,76:89:treatment,175:201:treatment,,320:328:treatment | A patient who receives induction therapy with lenalidomide, bortezomib and dexamethasone and achieves a PR or better but subsequently progresses on continued lenalidomide or lenalidomide-dexamethasone would be eligible provided the progression occurs 60 days or more after discontinuation of the bortezomib; similarly, i... | 2 | [
"A",
"patient",
"who",
"receives",
"induction",
"therapy",
"with",
"lenalidomide",
",",
"bortezomib",
"and",
"dexamethasone",
"and",
"achieves",
"a",
"PR",
"or",
"better",
"but",
"subsequently",
"progresses",
"on",
"continued",
"lenalidomide",
"or",
"lenalidomide-de... | [
0,
0,
0,
0,
1,
1,
1,
1,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02266329 | 26:67:treatment | Current participation in transcranial magnetic stimulation studies | 2 | [
"Current",
"participation",
"in",
"transcranial",
"magnetic",
"stimulation",
"studies"
] | [
0,
0,
0,
1,
1,
1,
1
] |
NCT02346253 | 51:69:treatment, | Clinically negative lymph nodes as established by abdomino-pelvic CT, no more than 90 days prior toregistration | 2 | [
"Clinically",
"negative",
"lymph",
"nodes",
"as",
"established",
"by",
"abdomino-pelvic",
"CT",
",",
"no",
"more",
"than",
"90",
"days",
"prior",
"toregistration"
] | [
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01849146 | 21:43:treatment | receiving any other investigational agents are ineligible | 2 | [
"receiving",
"any",
"other",
"investigational",
"agents",
"are",
"ineligible"
] | [
0,
0,
0,
1,
1,
0,
0
] |
NCT02101034 | 27:40:treatment,45:63:cancer,86:95:treatment | Phase I only: any (or no) prior therapy for metastatic disease is allowed, including cetuximab | 2 | [
"Phase",
"I",
"only",
":",
"any",
"(",
"or",
"no",
")",
"prior",
"therapy",
"for",
"metastatic",
"disease",
"is",
"allowed",
",",
"including",
"cetuximab"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
3,
3,
0,
0,
0,
0,
1
] |
NCT02188745 | 1:23:chronic_disease | deep venous thrombosis | 2 | [
"deep",
"venous",
"thrombosis"
] | [
2,
2,
2
] |
NCT02140554 | 18:30:treatment | Prior receipt of gene therapy | 2 | [
"Prior",
"receipt",
"of",
"gene",
"therapy"
] | [
0,
0,
0,
1,
1
] |
NCT02522715 | ,52:81:treatment,85:111:treatment,115:127:treatment, | Must have appropriate wash out (> 6 half-lives) of androgen receptor antagonists, 5 alpha reductase inhibitors or ketoconazole prior to the start of cycle 1; if the agent is not in the table below, the washout should be 2 weeks | 2 | [
"Must",
"have",
"appropriate",
"wash",
"out",
"(",
">",
"6",
"half-lives",
")",
"of",
"androgen",
"receptor",
"antagonists",
",",
"5",
"alpha",
"reductase",
"inhibitors",
"or",
"ketoconazole",
"prior",
"to",
"the",
"start",
"of",
"cycle",
"1",
";",
"if",
"... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
1,
1,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02914509 | 25:44:chronic_disease,,,98:117:chronic_disease,126:143:chronic_disease,181:206:chronic_disease | Documented diagnosis of ocular hypertension with an open angle of Schaffer Grade 3 or greater or open-angle glaucoma without pseudoexfoliation or pigment dispersion or evidence of traumatic angle recession | 2 | [
"Documented",
"diagnosis",
"of",
"ocular",
"hypertension",
"with",
"an",
"open",
"angle",
"of",
"Schaffer",
"Grade",
"3",
"or",
"greater",
"or",
"open-angle",
"glaucoma",
"without",
"pseudoexfoliation",
"or",
"pigment",
"dispersion",
"or",
"evidence",
"of",
"traum... | [
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
2,
0,
0,
0,
0,
0,
0,
2,
2,
2
] |
NCT02362308 | 1:17:chronic_disease | Type II Diabetes, as defined by ADA criteria | 2 | [
"Type",
"II",
"Diabetes",
",",
"as",
"defined",
"by",
"ADA",
"criteria"
] | [
2,
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT01434316 | 28:67:cancer,,163:172:treatment,181:198:treatment | patients with a history of central nervous system (CNS) metastases that have been treated must be stable with no symptoms for > 3 months after completion of that treatment and off steroid treatment, with image documentation required prior to study enrollment | 2 | [
"patients",
"with",
"a",
"history",
"of",
"central",
"nervous",
"system",
"(",
"CNS",
")",
"metastases",
"that",
"have",
"been",
"treated",
"must",
"be",
"stable",
"with",
"no",
"symptoms",
"for",
">",
"3",
"months",
"after",
"completion",
"of",
"that",
"t... | [
0,
0,
0,
0,
0,
3,
3,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02993406 | 1:32:chronic_disease | transient ischemic attack (TIA) | 2 | [
"transient",
"ischemic",
"attack",
"(",
"TIA",
")"
] | [
2,
2,
2,
2,
0,
0
] |
NCT02500147 | 30:46:chronic_disease | Past or present history of a medical disorder or medication known to affect body composition | 2 | [
"Past",
"or",
"present",
"history",
"of",
"a",
"medical",
"disorder",
"or",
"medication",
"known",
"to",
"affect",
"body",
"composition"
] | [
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT02181257 | ,81:122:chronic_disease,161:164:chronic_disease,173:182:chronic_disease,184:197:chronic_disease | Patients whose decline in lung function (FEV1) is related to either Restrictive Chronic Lung Allograft Dysfunction (CLAD) or other causes that do not represent BOS such as pneumonia, heart failure, etc | 2 | [
"Patients",
"whose",
"decline",
"in",
"lung",
"function",
"(",
"FEV1",
")",
"is",
"related",
"to",
"either",
"Restrictive",
"Chronic",
"Lung",
"Allograft",
"Dysfunction",
"(",
"CLAD",
")",
"or",
"other",
"causes",
"that",
"do",
"not",
"represent",
"BOS",
"su... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
2,
0,
2,
2,
0,
0
] |
NCT02266745 | 14:38:chronic_disease,,,,99:120:chronic_disease,122:146:chronic_disease,148:195:treatment,197:222:chronic_disease,227:245:chronic_disease,,285:295:treatment | Uncontrolled congestive heart failure (New York Heart Association Classification 3 or 4), angina, myocardial infarction, cerebrovascular accident, coronary/peripheral artery bypass graft surgery, transient ischemic attack, or pulmonary embolism within 3 months prior to initiation of study drug | 2 | [
"Uncontrolled",
"congestive",
"heart",
"failure",
"(",
"New",
"York",
"Heart",
"Association",
"Classification",
"3",
"or",
"4",
")",
",",
"angina",
",",
"myocardial",
"infarction",
",",
"cerebrovascular",
"accident",
",",
"coronary/peripheral",
"artery",
"bypass",
... | [
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
2,
2,
0,
1,
1,
1,
1,
1,
0,
2,
2,
2,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02374021 | 7:51:chronic_disease,58:84:chronic_disease,86:97:chronic_disease | other autoimmune and chronic inflammatory diseases (i.e. inflammatory bowel disease, sarcoidosis) | 2 | [
"other",
"autoimmune",
"and",
"chronic",
"inflammatory",
"diseases",
"(",
"i.e",
".",
"inflammatory",
"bowel",
"disease",
",",
"sarcoidosis",
")"
] | [
0,
2,
2,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
2,
0
] |
NCT01695967 | 1:19:chronic_disease | bleeding disorders | 2 | [
"bleeding",
"disorders"
] | [
2,
2
] |
NCT02411318 | 18:29:treatment | Currently taking medications that are not recommended to be taken in conjunction with alcohol | 2 | [
"Currently",
"taking",
"medications",
"that",
"are",
"not",
"recommended",
"to",
"be",
"taken",
"in",
"conjunction",
"with",
"alcohol"
] | [
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02762825 | 39:52:chronic_disease, | Any patient recently hospitalized for heart failure will have to wait at least 2 weeks before starting CR | 2 | [
"Any",
"patient",
"recently",
"hospitalized",
"for",
"heart",
"failure",
"will",
"have",
"to",
"wait",
"at",
"least",
"2",
"weeks",
"before",
"starting",
"CR"
] | [
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02838797 | 1:9:chronic_disease,, | Dementia (Mini Mental Status Exam < 25) | 2 | [
"Dementia",
"(",
"Mini",
"Mental",
"Status",
"Exam",
"<",
"25",
")"
] | [
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01822522 | 1:25:chronic_disease | Cardiovascular disorders | 2 | [
"Cardiovascular",
"disorders"
] | [
2,
2
] |
NCT02565199 | 49:52:treatment | The subjects must be comfortable when receiving TMS of all strengths | 2 | [
"The",
"subjects",
"must",
"be",
"comfortable",
"when",
"receiving",
"TMS",
"of",
"all",
"strengths"
] | [
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.